Multiple doctors have cautioned that a bird flu found in humans is likely the result of gain-of-function research, with Dr. Peter McCullough warning that a ‘vaccine’ would only create ‘more resistant strains.’

Biomedical Advanced Research and Development Authority (BARDA), a military contractor, has already helped develop a bird flu mRNA shot that has been cleared by the FDA, prompted by a bird flu outbreak in U.S. dairy cows. The vaccine development will include a late-stage trial next year if early testing looks promising, according to the Associated Press.

The mRNA injection is intended to remain flexible enough to provide immunity to flu strains aside from the H5N1 bird flu and be “quickly redirected to target” such a strain if needed, according to the U.S. Department of Health and Human Services (HHS).

The mRNA form of the so-called “vaccine” itself raises concerns considering the dangers inherent to the biotechnology and the abysmal track record of the mRNA COVID injections. Before the COVID outbreak, not one Moderna mRNA treatment had been brought to market since 2013, when it signed an agreement to develop and commercialize mRNA therapeutic treatments.